Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Capecitabine
Xeloda
Routinely available
SMC (716/11)
17/08/2011
Indication
In combination with oxaliplatin for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available
Formulation
150mg, 500mg tablets
Comments
August 2011 - Added to the Additional List, for Specialist Use only.